Drug results: 1

sunvozertinib Sunvozertinib is a kinase inhibitor of epidermal growth factor receptor (EGFR). Sunvozertinib inhibits EGFR signaling by binding to mutant EGFR, including exon 20 insertion mutations, resulting in inhibition of tumor cell proliferation.

DrugCentral Search Overview